PlainRecalls

Novartis Consumer Health

Compiled from official public sources by the publisher.

60 recalls on record · Latest: Mar 5, 2014

Subscribe to new Novartis Consumer Health recalls (RSS)

Agency notice ledger

Federal filing book Novartis Consumer Health MID-BOOK · MULTI-AGENCY

#295 of 14,151 · 60 notices · 0.057% archive

  • BOOK 60 notices
  • RANK #295 of 14,151
  • SHARE 0.057% archive
  • AGENCY FDA Drug (48)
  • CAT drugs
  • CATS 5 categories
  • LATEST Mar 5, 2014
  • PHOTO Fgf, LLC

Nearest notice-volume peer: Fgf, LLC (0 notice gap)

Novartis Consumer Health accounts for about 0.057% of the 104,423-notice archive on 60 distinct filings — a heavy share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

Where Novartis Consumer Health sits among 14,151 recalling firms

Novartis Consumer Health ranks 295th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Novartis Consumer Health vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

60 295th of 14151 higher than 13,855 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

Novartis Consumer Health in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Novartis Consumer Health holds about 0.057% of archive notices alongside 60 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026

How the 60 notices break down

Same federal filing book as the hero total — split by issuing agency, no new counts.

FDA Drug Low Jun 12, 2013

Novartis Lamisil AT Cream for Jock Itch (terbinafine hydrochloride 1% antifungal), a) 12 g (.42 oz) Tube, NDC 0067-3999-12, Novartis Consumer Health, Inc., Parsitan, NJ. UPC code: 300673999121, (Vertical Pack) and b) packaged in a horizontal package12 gm (.42 oz) Tube, NDC 0067-3999-42, Novartis Consumer Health, Inc., Parsippany, NJ. UPC code: 300673999428.
FDA Drug Low Jun 12, 2013

Lamisil AT Cream (terbinafine hydrochloride 1% antifungal), 12 gm ( .42 oz) Tubes and 30 gm (1 oz) Tubes packaged in one box, Novartis Consumer Health, Inc., Parsitan, NJ. UPC code: 300676249438. (Club Pack), NDC 0067-6295-43
FDA Drug Low Jun 12, 2013

Voltaren Gel (diclofenac sodium topical gel) 1%, for topical use only, RX only, a) Packaged in 20 gm tubes, NDC 63481-684-83 (physician sample product) and b) 100 gm tubes, NDC 63481-684-47 (the 100 g tubes are also packaged 3/100-g tubes/packs (UPC code: 363481684030 NDC code: 6348168403) and 5/100-g tubes/packs (UPC code: 363481684054 NDC code: 6348168405), Marketed by Endo Pharmaceuticals Inc., Chadds Ford, PA and Manufactured by Novartis Consumer Health, Inc, Parsippany, NJ.
FDA Drug Low Jun 12, 2013

Target Up & Up, athlete's foot cream, full prescription strength, terbinafine hydrochloride 1% antifungal, 30 g (1 oz), compare to active ingredient in Lamisil, NDC 0067-6382-30 & UPC code: 300676382302 (Novartis) Target NDC 1167-3401-04, Distributed by Target Corp., Minneapolis, MN.
FDA Drug Low May 29, 2013

Lamisil AT (terbinafine hydrochloride cream 1% antifungal), 24 g (.85 oz) tube, Novartis Consumer Health, Parsippany, NJ 07054, NDC 0067-6171-85
FDA Drug Low Mar 27, 2013

4 way Saline Moisturizing Mist with Eucalyptol & Menthol, 1-fl. oz. bottles, OTC. Distributed by Novartis Consumer Health, Inc., Parsippany, NJ 07054.
FDA Drug Low Mar 27, 2013

Nupercainal, Dibucaine, Hemorrhoidal & Topical Analgesic Ointment, a) 1-oz. tubes (NDC 0067-5812-96), b) 2-oz. tubes (NDC 0067-5812-86), OTC. Distributed by Novartis Consumer Health, Inc., Parsippany, NJ 07054.
FDA Drug Low Mar 27, 2013

4 way Nasal Decongestant Menthol Nasal Spray, containing phenylephrine hydrochloride 1%, a) 1/2-fl. oz. bottles (NDC 0067-2087-05) b) 1-fl. oz. bottles (NDC 0067-2087-01), OTC. Distributed by Novartis Consumer Health, Inc., Parsippany, NJ 07054.
FDA Drug Low Mar 27, 2013

4 way Nasal Decongestant Fast Acting Nasal Spray, containing phenylephrine hydrochloride 1%, a) 1/2-fl. oz. bottles (NDC 0067-2086-05), b) 1-fl. oz. bottles (NDC 0067-2086-01), c) 1.25-fl. oz. bottles (NDC 0067-2086-15), OTC. Distributed by Novartis Consumer Health, Inc., Parsippany, NJ 07054.
FDA Drug Low Mar 27, 2013

Myoflex (trolamine salicylate) 10%, Pain Relieving Cream, a) 2-oz tube, b) 4-oz. tube, OTC. The firm name on the label is Novartis Consumer Health, Inc., Parsippany, NJ 07054.

Novartis Consumer Health carries an outsized archive share

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar recall count

Nearest multi-notice firms by distinct-event totals (60 here — heavy-book).

Fgf, LLC 60 Peterbilt 60 Aesculap Implant Systems LLC 61 Correctional Industries Food Factory 61 RemedyRepack Inc. 61

Similar drugs volume

Nearest multi-notice firms sharing this firm's wide category mix.

RemedyRepack Inc. 61 American Health Packaging 59 Aurobindo Pharma USA Inc 59 Pharmacy Innovations 59

Frequently Asked Questions

How many federal recall notices name Novartis Consumer Health? ▼
PlainRecalls indexes 60 distinct federal recall events naming Novartis Consumer Health, aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Novartis Consumer Health sit among other recalling firms? ▼
Novartis Consumer Health ranks #295 of 14,151 by distinct recall-event count among 14,151 firms in this archive (98th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Novartis Consumer Health's notices? ▼
FDA Drug accounts for 48 of this firm's 60 indexed notices across 2 issuing agencies.
What product category dominates Novartis Consumer Health's filing book? ▼
Filings for Novartis Consumer Health span 5 product categories, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Novartis Consumer Health: 60 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Novartis Consumer Health; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026